151 related articles for article (PubMed ID: 19575326)
1. AZT 5'-triphosphate nanoformulation suppresses human immunodeficiency virus type 1 replication in peripheral blood mononuclear cells.
Saiyed ZM; Gandhi NH; Nair MP
J Neurovirol; 2009 Jul; 15(4):343-7. PubMed ID: 19575326
[TBL] [Abstract][Full Text] [Related]
2. Magnetic nanoformulation of azidothymidine 5'-triphosphate for targeted delivery across the blood-brain barrier.
Saiyed ZM; Gandhi NH; Nair MP
Int J Nanomedicine; 2010 Apr; 5():157-66. PubMed ID: 20463931
[TBL] [Abstract][Full Text] [Related]
3. Pharmacodynamic studies (PD) of didanosine (ddI) alone and in combination with azidothymidine (AZT) in human T-cells; a stochastic biochemical approach to antiretroviral nucleoside drug combination in inhibiting HIV-reverse transcriptase (RT).
Periclou AP; Nandy P; Avramis VI
In Vivo; 2000; 14(3):377-88. PubMed ID: 10904870
[TBL] [Abstract][Full Text] [Related]
4. A new antiviral: chimeric 3TC-AZT phosphonate efficiently inhibits HIV-1 in human tissues ex vivo.
Vanpouille C; Khandazhinskaya A; Karpenko I; Zicari S; Barreto-de-Souza V; Frolova S; Margolis L; Kochetkov S
Antiviral Res; 2014 Sep; 109():125-31. PubMed ID: 25010891
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxicity of 3'-azido-3'-deoxythymidine correlates with 3'-azidothymidine-5'-monophosphate (AZTMP) levels, whereas anti-human immunodeficiency virus (HIV) activity correlates with 3'-azidothymidine-5'-triphosphate (AZTTP) levels in cultured CEM T-lymphoblastoid cells.
Törnevik Y; Ullman B; Balzarini J; Wahren B; Eriksson S
Biochem Pharmacol; 1995 Mar; 49(6):829-37. PubMed ID: 7702641
[TBL] [Abstract][Full Text] [Related]
6. Effects of beta-L-3'-azido-3'-deoxythymidine 5'-triphosphate on host and viral DNA polymerases.
Faraj A; El Alaoui AM; Gosselin G; Imbach JL; Morrow C; Sommadossi JP
Antiviral Res; 2000 Aug; 47(2):97-102. PubMed ID: 10996397
[TBL] [Abstract][Full Text] [Related]
7. Non-nucleoside inhibitors of HIV-1 reverse transcriptase inhibit phosphorolysis and resensitize the 3'-azido-3'-deoxythymidine (AZT)-resistant polymerase to AZT-5'-triphosphate.
Odriozola L; Cruchaga C; Andréola M; Dollé V; Nguyen CH; Tarrago-Litvak L; Pérez-Mediavilla A; Martínez-Irujo JJ
J Biol Chem; 2003 Oct; 278(43):42710-6. PubMed ID: 12917424
[TBL] [Abstract][Full Text] [Related]
8. NMR study of dideoxynucleotides with anti-human immunodeficiency virus (HIV) activity.
Reddy DV; Jagannadh B; Kunwar AC
J Biochem Biophys Methods; 1996 Feb; 31(3-4):113-21. PubMed ID: 8675954
[TBL] [Abstract][Full Text] [Related]
9. Reverse transcriptases from human immunodeficiency virus type 1 (HIV-1), HIV-2, and simian immunodeficiency virus (SIVMAC) are susceptible to inhibition by foscarnet and 3'-azido-3'-deoxythymidine triphosphate.
Vrang L; Oberg B; Löwer J; Kurth R
Antimicrob Agents Chemother; 1988 Nov; 32(11):1733-4. PubMed ID: 2472774
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, anti-HIV activity and stability studies of 3'-azido-2',3'-dideoxythymidine 5'-fluorophosphate.
Egron D; Arzumanov AA; Dyatkina NB; Krayevsky A; Imbach JL; Aubertin AM; Gosselin G; Périgaud C
Nucleosides Nucleotides; 1999; 18(4-5):983-4. PubMed ID: 10432725
[TBL] [Abstract][Full Text] [Related]
11. Human immunodeficiency virus type 1 reverse transcriptase. 3'-Azidodeoxythymidine 5'-triphosphate inhibition indicates two-step binding for template-primer.
Jaju M; Beard WA; Wilson SH
J Biol Chem; 1995 Apr; 270(17):9740-7. PubMed ID: 7537269
[TBL] [Abstract][Full Text] [Related]
12. Intracellular metabolism and persistence of the anti-human immunodeficiency virus activity of 2',3'-didehydro-3'-deoxy-4'-ethynylthymidine, a novel thymidine analog.
Paintsil E; Dutschman GE; Hu R; Grill SP; Lam W; Baba M; Tanaka H; Cheng YC
Antimicrob Agents Chemother; 2007 Nov; 51(11):3870-9. PubMed ID: 17724147
[TBL] [Abstract][Full Text] [Related]
13. SiO₂ nanoparticles as platform for delivery of 3'-triazole analogues of AZT-triphosphate into cells.
Vasilyeva SV; Levina AS; Li-Zhulanov NS; Shatskaya NV; Baiborodin SI; Repkova MN; Zarytova VF; Mazurkova NA; Silnikov VN
Bioorg Med Chem; 2015 May; 23(9):2168-75. PubMed ID: 25801161
[TBL] [Abstract][Full Text] [Related]
14. Implication of the tRNA initiation step for human immunodeficiency virus type 1 reverse transcriptase in the mechanism of 3'-azido-3'-deoxythymidine (AZT) resistance.
Vaccaro JA; Anderson KS
Biochemistry; 1998 Oct; 37(40):14189-94. PubMed ID: 9760256
[TBL] [Abstract][Full Text] [Related]
15. Inhibitors of HIV-1 reverse transcriptase and fidelity of in vitro DNA replication.
Abbotts J; Wilson SH
J Enzyme Inhib; 1992; 6(1):35-46. PubMed ID: 1285301
[TBL] [Abstract][Full Text] [Related]
16. Biochemical characterization of a multi-drug resistant HIV-1 subtype AG reverse transcriptase: antagonism of AZT discrimination and excision pathways and sensitivity to RNase H inhibitors.
Schneider A; Corona A; Spöring I; Jordan M; Buchholz B; Maccioni E; Di Santo R; Bodem J; Tramontano E; Wöhrl BM
Nucleic Acids Res; 2016 Mar; 44(5):2310-22. PubMed ID: 26850643
[TBL] [Abstract][Full Text] [Related]
17. Telomerase-inhibitory effects of the triphosphate derivatives of some biologically active nucleosides.
Yamaguchi T; Takayama Y; Saito M; Ishikawa F; Saneyoshi M
Nucleic Acids Res Suppl; 2001; (1):211-2. PubMed ID: 12836339
[TBL] [Abstract][Full Text] [Related]
18. The Y181C substitution in 3'-azido-3'-deoxythymidine-resistant human immunodeficiency virus, type 1, reverse transcriptase suppresses the ATP-mediated repair of the 3'-azido-3'-deoxythymidine 5'-monophosphate-terminated primer.
Selmi B; Deval J; Alvarez K; Boretto J; Sarfati S; Guerreiro C; Canard B
J Biol Chem; 2003 Oct; 278(42):40464-72. PubMed ID: 12902345
[TBL] [Abstract][Full Text] [Related]
19. Nucleoside analog resistance caused by insertions in the fingers of human immunodeficiency virus type 1 reverse transcriptase involves ATP-mediated excision.
Boyer PL; Sarafianos SG; Arnold E; Hughes SH
J Virol; 2002 Sep; 76(18):9143-51. PubMed ID: 12186898
[TBL] [Abstract][Full Text] [Related]
20. New thymidine triphosphate analogue inhibitors of human immunodeficiency virus-1 reverse transcriptase.
Ma QF; Bathurst IC; Barr PJ; Kenyon GL
J Med Chem; 1992 May; 35(11):1938-41. PubMed ID: 1375962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
